Filter Results
:
(71)
Show Results For
-
All HBS Web
(333)
- News (71)
- Research (180)
- Events (1)
- Multimedia (3)
- Faculty Publications (44)
Show Results For
-
All HBS Web
(333)
- News (71)
- Research (180)
- Events (1)
- Multimedia (3)
- Faculty Publications (44)
Page 1 of
71
Results
→
Sort by
- 29 Oct 2015
- News
Options to Promote Competitive Generics Markets in the United States
- 01 Mar 2004
- News
Drug Imports a Hot Topic at Alumni Health-Care Conference
FDA Commissioner Mark B. McClellan doesn’t approve of Americans buying low-cost prescription drugs from Canada or over the Internet. But he understands what drives them to do so. At the HBS Health Industry Alumni Association’s fourth...
View Details
- 01 Mar 2007
- News
Daniel Vasella
sales of $37 billion. The company’s aggressive investment in research has made it an industry leader in new drug approvals. And when opportunity knocks, Vasella doesn’t hesitate to broaden Novartis’s business mix through acquisitions. He...
View Details
- 13 Oct 2016
- News
Study shows coupons lead to big profits for drugmakers
- 01 Dec 2023
- News
Wide Horizon
There were three critical events that led John Rodakis (MBA 1997) to form the nonprofit N of One in 2014 and ultimately dedicate his life to surfacing breakthrough autism research. The first occurred on Thanksgiving of 2012. He had driven about four hours with his wife...
View Details
Keywords:
Dan Morrell; Photos by Sarah Wilson
- 01 Sep 2023
- News
Solving for Z
With nearly 20 years of experience as a senior human resources executive, Matthew Breitfelder (MBA 2002) has seen a lot of change in the corporate talent space. But what’s happening now looks like a tectonic generational shift. From his perch as global head of human...
View Details
- 04 Apr 2024
- News
The Making of a Medical Milestone
On March 16, doctors at the Massachusetts General Hospital made history when they successfully transplanted a kidney from a genetically modified pig to a living human. The groundbreaking procedure marked a significant milestone in animal-to-human transplant, or...
View Details
Keywords:
Margie Kelley
- 01 Jun 2023
- News
From Big Pharma to Startup
Hunter Goble (MBA 2022) did not enroll in Harvard Business School with dreams of becoming an entrepreneur. After earning his MBA, Goble intended to return to Eli Lilly to continue to work building brands and launching products. He envisioned himself leading a big,...
View Details
Keywords:
April White
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without health care and wants to make drugs for children with rare diseases more accessible and affordable. Nora Rabah’s (MS/MBA...
View Details
- 01 Mar 2024
- News
Alumni and Faculty Books and Podcasts
Edited by Margie Kelley Alumni Books You Got This! A Straightforward, No-Nonsense Playbook for Crushing 130+ Workplace Challenges By Heidi Abelli (MBA 1993) Palmetto Publishing Stepping into the corporate world can feel like navigating a labyrinth, especially when...
View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
drug and the FDA says it is safe and effective and doctors prescribe it, insurance generally will pay for it. But everyone is getting fed up with that approach—the ‘Pharma bro’ Martin Shkreli did not...
View Details
- 01 Sep 2004
- News
American Dream
passing motorists. Hustead acquired the T. rex, for example, to drive demand for the fossils, rocks, and dinosaur-related products for sale in the Wall Drug Mining Company, one of 21 separate retail departments that View Details
- 01 Dec 2019
- News
The Race Against Resistance
tide. “If we don’t take steps to slow down or stop drug resistance, we will fall back to a time when simple infections killed people. Can you imagine? That’s a bit of a doomsday perspective, but it’s a call to action.” “We are approaching...
View Details
Keywords:
Lisa Scanlon Mogolov
- 01 Jun 2001
- News
Stephen M. Moret: A Campaign for Positive Change
low-cost HIV/AIDS drugs to Malawi. “I’m the guy who still can’t believe I got to go to school here.” After traveling around the world this fall, Moret will take a position in McKinsey’s Washington, D.C., office, where he hopes to spend...
View Details
- 01 Jun 2010
- News
$how Me the Money
Bank made a $160 million settlement with the Justice Department, agreeing it had been lax about accepting drug money from Mexico.) While U.S. law is tough on drug trafficking, terrorist financing, bank...
View Details
Keywords:
Garry Emmons;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support;
Executive, Legislative, and Other General Government Support
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that manufactures and sells...
View Details
- 01 Jun 2000
- News
The Business of Biotech
December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen (which restores white blood cells in cancer patients) generated more than $2 billion in sales last year. As the ability to analyze a patient's...
View Details
Keywords:
Julia Hanna
- 20 Aug 2014
- News
With No Time to Lose
into ALS research, and removed some critical barriers to the development of treatments. “Our focus, from the start, was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed with the disease in 2004, just weeks...
View Details
Keywords:
Margie Kelley
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
wants to understand the barriers to effecting change on global issues such as health care." Under Ray Gilmartin's leadership, Merck has launched an unprecedented number of new drugs and forged partnerships with the public and nonprofit...
View Details